Abstract
Temafloxacin disk susceptibility test criteria were evaluated by testing 697 bacterial isolates. Either 5- or 10-micrograms disks could be used satisfactorily. A 5-micrograms temafloxacin disk with zone size breakpoints of less than or equal to 12 mm for resistance (MIC, greater than 4.0 micrograms/ml) and greater than 16 mm for susceptibility (MIC, less than or equal to 2.0 micrograms/ml) is recommended.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barry A. L., Jones R. N. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test. Eur J Clin Microbiol. 1987 Apr;6(2):179–182. doi: 10.1007/BF02018204. [DOI] [PubMed] [Google Scholar]
- Barry A. L., Jones R. N. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents. J Antimicrob Chemother. 1989 Apr;23(4):527–535. doi: 10.1093/jac/23.4.527. [DOI] [PubMed] [Google Scholar]
- Chin N. X., Figueredo V. M., Novelli A., Neu H. C. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent. Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):58–63. doi: 10.1007/BF01962176. [DOI] [PubMed] [Google Scholar]
- Fuchs P. C., Barry A. L., Jones R. N., Thornsberry C. Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits. Diagn Microbiol Infect Dis. 1985 May;3(3):213–221. doi: 10.1016/0732-8893(85)90033-1. [DOI] [PubMed] [Google Scholar]
- Fuchs P. C., Barry A. L., Jones R. N., Thornsberry C. Proposed disk diffusion susceptibility criteria for ofloxacin. J Clin Microbiol. 1985 Aug;22(2):310–311. doi: 10.1128/jcm.22.2.310-311.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuchs P. C., Barry A. L., Jones R. N., Thornsberry C. Tentative disk diffusion susceptibility interpretive criteria for pefloxacin. J Clin Microbiol. 1986 Sep;24(3):448–450. doi: 10.1128/jcm.24.3.448-450.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuchs P. C., Jones R. N., Barry A. L., Ayers L. W., Gavan T. L., Gerlach E. H., Thornsberry C. RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria. Diagn Microbiol Infect Dis. 1987 May;7(1):29–35. doi: 10.1016/0732-8893(87)90066-6. [DOI] [PubMed] [Google Scholar]
- Fuchs P. C., Jones R. N., Barry A. L., Gavan T. L. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria. J Clin Microbiol. 1989 Jan;27(1):49–52. doi: 10.1128/jcm.27.1.49-52.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hardy D. J., Swanson R. N., Hensey D. M., Ramer N. R., Bower R. R., Hanson C. W., Chu D. T., Fernandes P. B. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. Antimicrob Agents Chemother. 1987 Nov;31(11):1768–1774. doi: 10.1128/aac.31.11.1768. [DOI] [PMC free article] [PubMed] [Google Scholar]